{"id":163826,"date":"2022-10-11T02:07:45","date_gmt":"2022-10-11T06:07:45","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/invios-to-present-at-upcoming-industry-and-investor-conferences\/"},"modified":"2024-08-18T11:45:36","modified_gmt":"2024-08-18T15:45:36","slug":"invios-to-present-at-upcoming-industry-and-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/invios-to-present-at-upcoming-industry-and-investor-conferences.php","title":{"rendered":"invIOs to present at upcoming industry and investor conferences"},"content":{"rendered":"<p><![CDATA[VIENNA, Austria, Oct.  11, 2022  (GLOBE NEWSWIRE) -- invIOs GmbH (\u201cinvIOs\u201d), a privately held biotechnology company developing novel therapies for cancer, today announces its participation at three upcoming industry and investor conferences: BIO-Europe, Inv\u20ac$tival Showcase and the Jefferies 2022 London Healthcare Conference.]]><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/11\/2531440\/0\/en\/invIOs-to-present-at-upcoming-industry-and-investor-conferences.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"invIOs to present at upcoming industry and investor conferences\">invIOs to present at upcoming industry and investor conferences<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more from the original source: invIOs to present at upcoming industry and investor conferences <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/invios-to-present-at-upcoming-industry-and-investor-conferences.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163826","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163826"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163826"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163826\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}